Posts

Showing posts with the label Metabolic Disorders

Market Demand : Liver Disease Treatment Market Globally Grow at a CAGR of 11.01% by Revenue During the Period 2017-2021

ResearchMoz presents professional and in-depth study of "Global Liver Disease Treatment Market 2017-2021". Liver is the largest organ of the body and can completely recover from damage. However, continuous strain on the liver, when treatment is delayed, for a prolonged period of time can lead to severe damage to the liver and can even be fatal. Viral hepatitis is one of the major liver diseases affecting a large number of people across the globe. This is caused by viral infections and spread through contaminated food and water. Poor sanitation facilities in developing countries such as India and China has led to a higher prevalence of the disease in these countries. There has been a rise in healthcare investment in these countries. Technavios analysts forecast the global liver disease treatment market to grow at a CAGR of 11.01% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global liver disease tr...

Global Respiratory Drugs Market Will Grow At A CAGR Of 6.48% During The Period 2017-2020

ResearchMoz presents professional and in-depth study of "Global Respiratory Drugs Market 2016-2020". Asthma, COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and IPF are some of the major respiratory diseases. Among these, asthma and COPD are the most prevalent worldwide. Environmental pollution, changing lifestyles, and hereditary factors are some of the common causes of respiratory diseases. Intranasal corticosteroids, antihistamines, immunosuppressants, bronchodilators, and leukotriene antagonists are the respiratory medicines that are commonly used for the treatment of mild-to-moderate respiratory diseases. However, the choice of drug depends on the type and severity of the disease. Technavios analysts forecast the global respiratory drugs market to grow at a CAGR of 6.48% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global respiratory drugs market for 2016-2020. To calculate ...